SERAGENE THERAPEUTICS INC.
$33,505.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
FY 2025-2026
Canada
The project will support a pilot study for the lead asset - an siRNA for treatment of a bleeding disorder.